ES2092206T3 - Medicamentos que contienen un compuesto de imidazol-1-ilo. - Google Patents

Medicamentos que contienen un compuesto de imidazol-1-ilo.

Info

Publication number
ES2092206T3
ES2092206T3 ES93118167T ES93118167T ES2092206T3 ES 2092206 T3 ES2092206 T3 ES 2092206T3 ES 93118167 T ES93118167 T ES 93118167T ES 93118167 T ES93118167 T ES 93118167T ES 2092206 T3 ES2092206 T3 ES 2092206T3
Authority
ES
Spain
Prior art keywords
ilo
imidazole
compound
medicines containing
anomalies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93118167T
Other languages
English (en)
Inventor
Christian Eeckhout
Ulf Preuschoff
Samuel David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Application granted granted Critical
Publication of ES2092206T3 publication Critical patent/ES2092206T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE DESCRIBE LA UTILIZACION DE COMPUESTOS IMIDAZOL-1-ILO DE LA FORMULA GENERAL I DONDE R1 SIGNIFICA ALQUILO INFERIOR O HIDROGENO, M ES 2 O 3 Y N ES 2 O 3, Y SUS SALES DE ADICION ACIDA TOLERABLES FISIOLOGICAMENTE PARA LA ELABORACION DE PREPARACIONES FARMACEUTICAS PARA EL TRATAMIENTO DE TRASTORNOS FUNCIONALES UNIDOS A SENSIBILIDAD DOLOROSA ELEVADA Y/O ANOMALIAS DEL PASO EN LA ZONA DEL COLON DE LAS VIAS INTESTINALES INFERIORES EN MAMIFEROS GRANDES Y SERES HUMANOS.
ES93118167T 1992-11-14 1993-11-10 Medicamentos que contienen un compuesto de imidazol-1-ilo. Expired - Lifetime ES2092206T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238553A DE4238553A1 (de) 1992-11-14 1992-11-14 Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES2092206T3 true ES2092206T3 (es) 1996-11-16

Family

ID=6472938

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93118167T Expired - Lifetime ES2092206T3 (es) 1992-11-14 1993-11-10 Medicamentos que contienen un compuesto de imidazol-1-ilo.

Country Status (24)

Country Link
US (1) US5438068A (es)
EP (1) EP0601345B1 (es)
JP (1) JP3683286B2 (es)
KR (1) KR100266715B1 (es)
CN (1) CN1041053C (es)
AT (1) ATE143597T1 (es)
AU (1) AU667243B2 (es)
CA (3) CA2504502A1 (es)
CZ (1) CZ284154B6 (es)
DE (2) DE4238553A1 (es)
DK (1) DK0601345T3 (es)
DZ (1) DZ1726A1 (es)
ES (1) ES2092206T3 (es)
GR (1) GR3021230T3 (es)
HK (1) HK1006537A1 (es)
HU (1) HU213506B (es)
IL (1) IL107454A (es)
MX (1) MX9307079A (es)
NO (1) NO303926B1 (es)
NZ (1) NZ250103A (es)
PH (1) PH30702A (es)
RU (1) RU2125877C1 (es)
SK (1) SK278874B6 (es)
ZA (1) ZA938463B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
EP0297651B1 (en) * 1987-06-29 1993-11-03 Duphar International Research B.V Anellated indole derivatives

Also Published As

Publication number Publication date
HUT65978A (en) 1994-08-29
IL107454A0 (en) 1994-02-27
US5438068A (en) 1995-08-01
SK123593A3 (en) 1994-09-07
NO934090L (es) 1994-05-16
DK0601345T3 (da) 1996-11-18
HK1006537A1 (en) 1999-03-05
SK278874B6 (sk) 1998-04-08
JPH06211656A (ja) 1994-08-02
CZ284154B6 (cs) 1998-08-12
CZ236593A3 (en) 1994-05-18
GR3021230T3 (en) 1997-01-31
NO303926B1 (no) 1998-09-28
CA2538177A1 (en) 1994-05-15
ZA938463B (en) 1994-08-01
CA2102960C (en) 2005-08-02
KR940010999A (ko) 1994-06-20
MX9307079A (es) 1994-05-31
JP3683286B2 (ja) 2005-08-17
HU213506B (en) 1997-07-28
NO934090D0 (no) 1993-11-12
EP0601345A1 (de) 1994-06-15
KR100266715B1 (ko) 2000-09-15
RU2125877C1 (ru) 1999-02-10
PH30702A (en) 1997-09-16
CN1041053C (zh) 1998-12-09
CA2102960A1 (en) 1994-05-15
IL107454A (en) 1999-12-22
CA2504502A1 (en) 1994-05-15
AU667243B2 (en) 1996-03-14
ATE143597T1 (de) 1996-10-15
EP0601345B1 (de) 1996-10-02
NZ250103A (en) 1997-06-24
DZ1726A1 (fr) 2002-02-17
DE59304045D1 (de) 1996-11-07
AU5064393A (en) 1994-05-26
CN1092650A (zh) 1994-09-28
DE4238553A1 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
LU91223I2 (fr) Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan)
GB9514473D0 (en) Chemical compounds
ES2102195T3 (es) Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
FI974447A (fi) Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet
DE69310602D1 (de) 3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität
ES2092206T3 (es) Medicamentos que contienen un compuesto de imidazol-1-ilo.
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
MY113062A (en) Amide derivatives and their therapeutic use
TR199800714T2 (xx) Yeni $(3-Alkoksi-fenoksi)-etil]-dialkilamin t�revleri.
ES2143675T3 (es) Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
GR3005101T3 (es)
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
ZA828877B (en) Therapeutically useful 3,7a-diazacyclohepta(j,k)fluorene derivatives
DE69419083D1 (de) Salmycine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
YU49004B (sh) LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE
ES2103232A1 (es) Nuevos compuestos derivados de 1h-imidazol-2-metanol.
TH32887A (th) สารประกอบทางเคมี

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 601345

Country of ref document: ES